This is the
talk page for discussing improvements to the
Psychedelic drug article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1 |
![]() | This ![]() It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
![]() | The contents of the Serotonergic psychedelic page were merged into Psychedelic drug on 22 December 2022. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
This article was the subject of a Wiki Education Foundation-supported course assignment, between 14 January 2020 and 5 May 2020. Further details are available
on the course page. Student editor(s):
Tocollins. Peer reviewers:
ClaudiaBecker.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT ( talk) 07:24, 17 January 2022 (UTC)
Replaced with a more proper one: "A fractal pattern, similar in some respects to what may some people stereotipically associates with a psychedelic experience".
See discussion above for support on the modification. -- Δ Mr. Nighttime Δ ( talk) 14:36, 15 July 2010 (UTC)
Is the picture...relevant? The caption reads 'A fractal pattern, similar in some respects to what may be seen during a psychedelic experience' but without being an expert in psychiatry, it strikes me that pretty much anything 'may be seen during a psychedelic experience' 163.1.209.71 ( talk) 15:23, 16 November 2009 (UTC)
My name is JP. I apologize beforehand if I do not follow the accepted protocol for expressing my opinion about this page. I think that talkheader has a valid point: if we want to put a picture with the caption "A fractal pattern, similar in some respects to what may be seen during a psychedelic experience" we should probably probably be able to cite a source which backs up our claims... —Preceding unsigned comment added by 199.111.239.250 ( talk) 09:02, 3 December 2009 (UTC)
I think the word hallucinogen misleads many people who have never taken a psychedelic drug. As Albert Hofmann said "a hallucination is when you see something that does not exist, but when you take LSD everything that does exist becomes transformed. It is an alternative experience of our existence." I personally have never had any hallucinations in the true sense of the word during any of my trips. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 16:54, 2 May 2016 (UTC)
Salvia is a dissociative as mentioned in its own page and in the main psychedelics, dissociatives and deliriants page. It should not really be on the psychedelics page as this just adds to the popular misconception that it is a psychedelic as opposed to a dissociative. Maybe it could be replaced with a section on how high dose dissociatives often produce similar effects to psychedelics and so can be confused, an interesting example being Salvia whose active ingredient Salvinorin A is so potent that these effects are often noticed even with a small dose. Any thoughts? -Matt
Someone wrote: "Many pharmacologists define psychedelic drugs solely as chemicals that have an LSD- or mescaline-like action, working on the serotonin 5-HT2A receptor in the brain."
I'm quite sure that's not true. I'm sure enough that instead of putting a citation needed tag, I'm cutting it out and replacing it with something accurate. AlkaloidMan ( talk) 08:05, 31 October 2010 (UTC)AlkaloidMan
I added the following sentence to the end of the first paragraph:
"With a few exceptions, most psychedelic drugs fall into one of the two following families of chemical compounds; tryptamines [more specifically: alkylated tryptamines], and phenethylamines [more specifically: alkoxylated phenethylamines]."
I find this statement to be true; Cannabis & its psychoactive compounds (namely Δ9-THC, CBD, & CBN), as well as Salvia divinorum, are among the few exceptions... but almost all of the 200+ psychedelic compounds fall into one of those two categories. Even LSD, despite technically being an ergoline compound, contains a tryptamine backbone (hence its 5-HT receptor agonist effects).
I also edited the following sentence within the first paragraph:
"The psychedelic experience is often compared to non-ordinary forms of consciousness such as trance, meditation, yoga, religious fervor, dreaming and even near-death experiences."
to...
"The psychedelic experience is often compared to non-ordinary forms of consciousness such as trance, meditation, yoga, religious ecstasy, dreaming and even near-death experiences."
...as the page religious fervor does not exist. If anyone wishes to dispute this, please let me know. I am aware that not all psychedelic-induced religious experiences are ecstatic, but I could not find an existing page which was a sufficient synonym for religious fervor, so I went with religious ecstasy. If others insist, we can change it back, despite the page religious fervor being nonexistent... perhaps somebody could create one for it.
http://en.wikipedia.org/wiki/Psychoactive_drug Should that article and this one be merged? Aren't they about the same thing? — Preceding unsigned comment added by 75.158.72.234 ( talk) 05:14, 27 December 2014 (UTC)
I just made this illustration in latex. Maybe something like this should be on this webpage?
Zanthius ( talk) 13:27, 25 January 2015 (UTC)
The general psychological effects section should be removed (or reduced), because from having experience with different types of psychedelics (5HT2A receptor agonists, NMDA receptor antagonists and κ-Opioid receptor agonists) I think the experiences are very different. Maybe you should have a very small section describing the general criterias for defining a drug as a psychedelic (for example hallucinatory effects), but much more empathesis should be put on the psychological effects of different receptor interactions. I also think you could devide the general effects section into sections like "psychedelics and spirituality", "psychedelic act", "chemistry of psychedelics", "psychedelics and drug abuse", "possible adverse effects of psychedelics", and so on. And why hasn't this page been merged with the hallucinogens page? Zanthius ( talk) 14:07, 25 January 2015 (UTC)
I think any entheogen could potentially be either euphoric or dysphoric depending on set and setting. Like cannabis, I personally have always thought of salvia divinorum to be in its own category due to its unique mechanism of action. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 06:37, 1 May 2016 (UTC)
> Salvia D. is considered to be more dissociative than a dysphoriant. A substance does not have to be an NMDA antagonist to be a dissociative. −
I don't see why we need to have this massive, ultra-detailed description of what it's like to go on a trip. For starters, there is already a whole article just about the experience of being on hallucinogens. Thus, THIS page ought to be about the DRUGS, not the experience of being on them (which is subjective and varies between people and drugs used, amount used, etc). It also appears to be one massive quote taken directly from someone elses work. Large amounts of quoted text are frowned upon on wikipedia, and it's not even clear that it IS a quote (no quotation marks even), or what it's from (I presume from the text referenced in the paragraph above, but it's not 100% clear). As far as the quoted text goes, it doesn't strike me as particularly neutral. It may be perfectly factual, but some people may dislike its seeming positive spin on the experience, and the tone doesn't fit well in an "encyclopedic" article anyway. I mean, "Each drug experience is a unique journey of exploration into the mind." That is the opinion of the person who wrote it, and other people would call it utter bullshit. Thus I don't think that it belongs on this page. A quick summary of what it says, written in your own words, and with a clinical, neutral tone to it is what should be here. .45Colt 01:14, 30 October 2015 (UTC)
The vast majority of people who would call it "utter bullshit" have most likely never tried a psychedelic drug. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 06:40, 1 May 2016 (UTC)
MonikaWanis ( talk) 14:26, 21 November 2017 (UTC) My planned contributions are the following: - Provide a definition of what drugs are and how psychedelic drugs are a subset. - Define what specifically psychedelic drugs are and how they differ from other classes of drugs. - Provide information about the prevalence of psychedelic drug use and information about who uses these substances, in which settings they are most frequently used in and why. - Expand upon the history section to include information about the discovery of psychedelic drugs, the history of psychedelic drug use over time, and what known psychedelic drugs are out there. - I would include the medical uses of psychedelic drugs, what current research has to say about them, and what their legality status is. - Include the positive reported effects of psychedelic drugs as well as their negative side effects.
MonikaWanis ( talk) 15:03, 21 November 2017 (UTC) A list of potential journal articles that I will be using: Baker, John R. (1994). Consciousness Alteration as a Problem-Solving Device: The Psychadelic Pathway. Yearbook for Ethnomedicine and the Study of Consciousness, 3, 51-89.
Brecher, E. M. (1972). Licit and illicit drugs (p. 359). Boston: Little, Brown.
BRUHN, B. P., PSYCH, C., & MAAGE, N. (1975). Intellectual and Neuropsychological Functions in Young Men with Heavy and. Am J Psychiatry, 132(4).
Charvat, J. L. (1998). Barriers to effective drug abuse prevention: The role of authoritarian ideology. Journal of psychoactive drugs, 30(1), 69-79.
Fisher, G. (1963). Some Comments Concerning Dosage Levels of Psychedelic Compounds for Psycho-therapeutic Experiences. Psychedelic Review, 1, 208-218.
Gouzoulis-Mayfrank, E., Habermeyer, E., Hermle, L., Steinmeyer, A. M., Kunert, H. J., & Sass, H. (1998). Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study. European psychiatry, 13(8), 399-406.
Halpern, J. H., & Pope,Harrison G.,,Jr. (2001). Hallucinogens on the internet: A vast new source of underground drug information. The American Journal of Psychiatry, 158(3), 481-3. Retrieved from https://search.proquest.com/docview/220458998?accountid=14472
Halpern, J. H., & Pope, H. G. (1999). Do hallucinogens cause residual neuropsychological toxicity?. Drug and alcohol dependence, 53(3), 247-256.
Jacob, P. I. I. I., & Shulgin, A. T. (1994). Structure-activity relationships of classic hallucinogens and their analogs. NIDA research monograph, 146, 74-91.
McKenna, D. J. (1995). Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behavioural brain research, 73(1), 109-116.
Micke, M. M. (1996). The case of hallucinogenic plants and the internet. The Journal of School Health, 66(8), 277-280. Retrieved from https://search.proquest.com/docview/215682451?accountid=14472 Rosenthal, S. H. (1964). Persistent hallucinosis following repeated administration of hallucinogenic drugs. American Journal of Psychiatry, 121(3), 238-244.
Mogar, R. E., & Aldrich, R. W. (1969). The use of psychedelic agents with autistic schizophrenic children. Psychedelic Review, 10, 5-13.
Salzman, C., KOCHANSKY, G. E., SHADER, R. I., & LIEFF, J. (1972). The psychology of hallucinogenic drug discontinuers. American Journal of Psychiatry, 129(6), 755-761.
Schultes, R. E. (1970). The botanical and chemical distribution of hallucinogens. Annual Review of Plant Physiology, 21(1), 571-598.
Schultes, R. E. (1979). Hallucinogenic plants: their earliest botanical descriptions. Journal of psychedelic drugs, 11(1-2), 13-24.
Shulgin, A. T. (1976). DMT & TMA-2. Journal of Psychedelic Drugs, 8(2), 167-169.
Spruce, R. (1975). t Indole Alkaloids In Plant Hallucinogens. Journal of Psychedelic Drugs.
Szara, S. (1967). The Hallucinogenic Drugs—Curse or Blessing?. American Journal of Psychiatry, 123(12), 1513-1518.
This article seems to be quite off-date and a bit misleading. Tryptamines like LSD, psilocybin and DMT bind at many different receptors at different strength. I've read of activity at D1, A2A, A2B, A2C, and tryptamines tend to also bind to many different serotonin receptors. For example psilocin and mescaline bind strongly to 5ht2b, but psilocin is only moderately active at 5ht2a and mescaline not at all. Or so my notes say, but I don't have a reliable source available. Just a heads up if anyone is paying attention. — Preceding unsigned comment added by 80.222.148.189 ( talk) 21:10, 9 April 2019 (UTC)
The following Wikimedia Commons file used on this page has been nominated for deletion:
Participate in the deletion discussion at the nomination page. — Community Tech bot ( talk) 22:22, 13 January 2020 (UTC)
There was a thread a few years ago on the proper scope of this page, which reached no definitive conclusion, but I think the matter needs to be settled. Basically the question comes down to this: should the page have a broad scope as it does now, covering (classic) psychedelics, empathogens, dissociatives, deliriants, and cannabinergics, or should it have a narrower scope, covering only classic psychedelics? Unfortunately, pages already exist corresponding to both those possible scopes: Hallucinogen and Serotonergic psychedelic respectively. Therefore, regardless of which names should be used for the pages for the two concepts, there is a problem because there are three pages.
This is what I think should be done. This page should then be reduced in scope to only cover classic psychedelics. This seems preferable to the topic being covered on the page "Serotonergic psychedelic," since that is a more technical term and in any case not the term used in most of the literature based on my sampling; that page's content can be merged into this one's, and it can become a redirect. Then, I think this page should have a longer section on nomenclature similar to the one on the "Hallucinogen" page to clear up confusion among readers. At the top of the article it could say "Psychedelics, serotonergic psychedelics, classic psychedelics, or classic hallucinogens are ...", to make immediately clear that several names are used for the same thing.
I wanted to check with other editors before making big changes, but if my plan sounds good, I will go ahead and start moving content on the other hallucinogens to the "Hallucinogen" page. Then I could propose a merger and the material from "Serotonergic psychedelic" could be moved here. Gazelle55 ( talk) 01:25, 27 May 2020 (UTC)
Based on my post just above, I'd like to formally propose merging Serotonergic psychedelic into this page. This page has only covered serotonergic/classic psychedelics for some time now and there is no reason to have two pages for the same concept (see above). There isn't much material on the other page anyway so it could easily be integrated here. Furthermore, the less common, broader definition of psychedelic drug is already covered at the article Hallucinogen. Following the merger, I would bring together some sources to clarify the confusing and sometimes overlapping uses of the terminology for readers. Gazelle55 ( talk) 16:28, 12 May 2022 (UTC)
A conversation about this article took place here. OP is concerned that the risks of psychedelics are under-emphasized in the article. Most of the responses are invocations of WP:FALSEBALANCE, WP:FRINGE, WP:OR, and so on. I think these all miss the point. You can see my comment there for more background. However, here is the final paragraph of my comment, which will hopefully start a collaborative discussion about how to improve the article pursuant to OP's concerns:
"I think a concrete improvement that can be made to the article to address OP's well-founded concerns is to include a mention of the "Potential adverse effects" section in the lede, rather than only presenting positive information in the lede. These adverse effects would ideally be mentioned directly after the passage that states "psychedelics are physiologically safe." Pecopteris ( talk) 19:39, 27 September 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 March 2024 and 4 May 2024. Further details are available
on the course page. Student editor(s):
Kph7917 (
article contribs).
— Assignment last updated by Kph7917 ( talk) 17:44, 1 April 2024 (UTC)
This is the
talk page for discussing improvements to the
Psychedelic drug article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1 |
![]() | This ![]() It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
![]() | The contents of the Serotonergic psychedelic page were merged into Psychedelic drug on 22 December 2022. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
This article was the subject of a Wiki Education Foundation-supported course assignment, between 14 January 2020 and 5 May 2020. Further details are available
on the course page. Student editor(s):
Tocollins. Peer reviewers:
ClaudiaBecker.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT ( talk) 07:24, 17 January 2022 (UTC)
Replaced with a more proper one: "A fractal pattern, similar in some respects to what may some people stereotipically associates with a psychedelic experience".
See discussion above for support on the modification. -- Δ Mr. Nighttime Δ ( talk) 14:36, 15 July 2010 (UTC)
Is the picture...relevant? The caption reads 'A fractal pattern, similar in some respects to what may be seen during a psychedelic experience' but without being an expert in psychiatry, it strikes me that pretty much anything 'may be seen during a psychedelic experience' 163.1.209.71 ( talk) 15:23, 16 November 2009 (UTC)
My name is JP. I apologize beforehand if I do not follow the accepted protocol for expressing my opinion about this page. I think that talkheader has a valid point: if we want to put a picture with the caption "A fractal pattern, similar in some respects to what may be seen during a psychedelic experience" we should probably probably be able to cite a source which backs up our claims... —Preceding unsigned comment added by 199.111.239.250 ( talk) 09:02, 3 December 2009 (UTC)
I think the word hallucinogen misleads many people who have never taken a psychedelic drug. As Albert Hofmann said "a hallucination is when you see something that does not exist, but when you take LSD everything that does exist becomes transformed. It is an alternative experience of our existence." I personally have never had any hallucinations in the true sense of the word during any of my trips. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 16:54, 2 May 2016 (UTC)
Salvia is a dissociative as mentioned in its own page and in the main psychedelics, dissociatives and deliriants page. It should not really be on the psychedelics page as this just adds to the popular misconception that it is a psychedelic as opposed to a dissociative. Maybe it could be replaced with a section on how high dose dissociatives often produce similar effects to psychedelics and so can be confused, an interesting example being Salvia whose active ingredient Salvinorin A is so potent that these effects are often noticed even with a small dose. Any thoughts? -Matt
Someone wrote: "Many pharmacologists define psychedelic drugs solely as chemicals that have an LSD- or mescaline-like action, working on the serotonin 5-HT2A receptor in the brain."
I'm quite sure that's not true. I'm sure enough that instead of putting a citation needed tag, I'm cutting it out and replacing it with something accurate. AlkaloidMan ( talk) 08:05, 31 October 2010 (UTC)AlkaloidMan
I added the following sentence to the end of the first paragraph:
"With a few exceptions, most psychedelic drugs fall into one of the two following families of chemical compounds; tryptamines [more specifically: alkylated tryptamines], and phenethylamines [more specifically: alkoxylated phenethylamines]."
I find this statement to be true; Cannabis & its psychoactive compounds (namely Δ9-THC, CBD, & CBN), as well as Salvia divinorum, are among the few exceptions... but almost all of the 200+ psychedelic compounds fall into one of those two categories. Even LSD, despite technically being an ergoline compound, contains a tryptamine backbone (hence its 5-HT receptor agonist effects).
I also edited the following sentence within the first paragraph:
"The psychedelic experience is often compared to non-ordinary forms of consciousness such as trance, meditation, yoga, religious fervor, dreaming and even near-death experiences."
to...
"The psychedelic experience is often compared to non-ordinary forms of consciousness such as trance, meditation, yoga, religious ecstasy, dreaming and even near-death experiences."
...as the page religious fervor does not exist. If anyone wishes to dispute this, please let me know. I am aware that not all psychedelic-induced religious experiences are ecstatic, but I could not find an existing page which was a sufficient synonym for religious fervor, so I went with religious ecstasy. If others insist, we can change it back, despite the page religious fervor being nonexistent... perhaps somebody could create one for it.
http://en.wikipedia.org/wiki/Psychoactive_drug Should that article and this one be merged? Aren't they about the same thing? — Preceding unsigned comment added by 75.158.72.234 ( talk) 05:14, 27 December 2014 (UTC)
I just made this illustration in latex. Maybe something like this should be on this webpage?
Zanthius ( talk) 13:27, 25 January 2015 (UTC)
The general psychological effects section should be removed (or reduced), because from having experience with different types of psychedelics (5HT2A receptor agonists, NMDA receptor antagonists and κ-Opioid receptor agonists) I think the experiences are very different. Maybe you should have a very small section describing the general criterias for defining a drug as a psychedelic (for example hallucinatory effects), but much more empathesis should be put on the psychological effects of different receptor interactions. I also think you could devide the general effects section into sections like "psychedelics and spirituality", "psychedelic act", "chemistry of psychedelics", "psychedelics and drug abuse", "possible adverse effects of psychedelics", and so on. And why hasn't this page been merged with the hallucinogens page? Zanthius ( talk) 14:07, 25 January 2015 (UTC)
I think any entheogen could potentially be either euphoric or dysphoric depending on set and setting. Like cannabis, I personally have always thought of salvia divinorum to be in its own category due to its unique mechanism of action. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 06:37, 1 May 2016 (UTC)
> Salvia D. is considered to be more dissociative than a dysphoriant. A substance does not have to be an NMDA antagonist to be a dissociative. −
I don't see why we need to have this massive, ultra-detailed description of what it's like to go on a trip. For starters, there is already a whole article just about the experience of being on hallucinogens. Thus, THIS page ought to be about the DRUGS, not the experience of being on them (which is subjective and varies between people and drugs used, amount used, etc). It also appears to be one massive quote taken directly from someone elses work. Large amounts of quoted text are frowned upon on wikipedia, and it's not even clear that it IS a quote (no quotation marks even), or what it's from (I presume from the text referenced in the paragraph above, but it's not 100% clear). As far as the quoted text goes, it doesn't strike me as particularly neutral. It may be perfectly factual, but some people may dislike its seeming positive spin on the experience, and the tone doesn't fit well in an "encyclopedic" article anyway. I mean, "Each drug experience is a unique journey of exploration into the mind." That is the opinion of the person who wrote it, and other people would call it utter bullshit. Thus I don't think that it belongs on this page. A quick summary of what it says, written in your own words, and with a clinical, neutral tone to it is what should be here. .45Colt 01:14, 30 October 2015 (UTC)
The vast majority of people who would call it "utter bullshit" have most likely never tried a psychedelic drug. 2605:A000:1200:4020:BDC2:282A:6C52:766B ( talk) 06:40, 1 May 2016 (UTC)
MonikaWanis ( talk) 14:26, 21 November 2017 (UTC) My planned contributions are the following: - Provide a definition of what drugs are and how psychedelic drugs are a subset. - Define what specifically psychedelic drugs are and how they differ from other classes of drugs. - Provide information about the prevalence of psychedelic drug use and information about who uses these substances, in which settings they are most frequently used in and why. - Expand upon the history section to include information about the discovery of psychedelic drugs, the history of psychedelic drug use over time, and what known psychedelic drugs are out there. - I would include the medical uses of psychedelic drugs, what current research has to say about them, and what their legality status is. - Include the positive reported effects of psychedelic drugs as well as their negative side effects.
MonikaWanis ( talk) 15:03, 21 November 2017 (UTC) A list of potential journal articles that I will be using: Baker, John R. (1994). Consciousness Alteration as a Problem-Solving Device: The Psychadelic Pathway. Yearbook for Ethnomedicine and the Study of Consciousness, 3, 51-89.
Brecher, E. M. (1972). Licit and illicit drugs (p. 359). Boston: Little, Brown.
BRUHN, B. P., PSYCH, C., & MAAGE, N. (1975). Intellectual and Neuropsychological Functions in Young Men with Heavy and. Am J Psychiatry, 132(4).
Charvat, J. L. (1998). Barriers to effective drug abuse prevention: The role of authoritarian ideology. Journal of psychoactive drugs, 30(1), 69-79.
Fisher, G. (1963). Some Comments Concerning Dosage Levels of Psychedelic Compounds for Psycho-therapeutic Experiences. Psychedelic Review, 1, 208-218.
Gouzoulis-Mayfrank, E., Habermeyer, E., Hermle, L., Steinmeyer, A. M., Kunert, H. J., & Sass, H. (1998). Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study. European psychiatry, 13(8), 399-406.
Halpern, J. H., & Pope,Harrison G.,,Jr. (2001). Hallucinogens on the internet: A vast new source of underground drug information. The American Journal of Psychiatry, 158(3), 481-3. Retrieved from https://search.proquest.com/docview/220458998?accountid=14472
Halpern, J. H., & Pope, H. G. (1999). Do hallucinogens cause residual neuropsychological toxicity?. Drug and alcohol dependence, 53(3), 247-256.
Jacob, P. I. I. I., & Shulgin, A. T. (1994). Structure-activity relationships of classic hallucinogens and their analogs. NIDA research monograph, 146, 74-91.
McKenna, D. J. (1995). Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behavioural brain research, 73(1), 109-116.
Micke, M. M. (1996). The case of hallucinogenic plants and the internet. The Journal of School Health, 66(8), 277-280. Retrieved from https://search.proquest.com/docview/215682451?accountid=14472 Rosenthal, S. H. (1964). Persistent hallucinosis following repeated administration of hallucinogenic drugs. American Journal of Psychiatry, 121(3), 238-244.
Mogar, R. E., & Aldrich, R. W. (1969). The use of psychedelic agents with autistic schizophrenic children. Psychedelic Review, 10, 5-13.
Salzman, C., KOCHANSKY, G. E., SHADER, R. I., & LIEFF, J. (1972). The psychology of hallucinogenic drug discontinuers. American Journal of Psychiatry, 129(6), 755-761.
Schultes, R. E. (1970). The botanical and chemical distribution of hallucinogens. Annual Review of Plant Physiology, 21(1), 571-598.
Schultes, R. E. (1979). Hallucinogenic plants: their earliest botanical descriptions. Journal of psychedelic drugs, 11(1-2), 13-24.
Shulgin, A. T. (1976). DMT & TMA-2. Journal of Psychedelic Drugs, 8(2), 167-169.
Spruce, R. (1975). t Indole Alkaloids In Plant Hallucinogens. Journal of Psychedelic Drugs.
Szara, S. (1967). The Hallucinogenic Drugs—Curse or Blessing?. American Journal of Psychiatry, 123(12), 1513-1518.
This article seems to be quite off-date and a bit misleading. Tryptamines like LSD, psilocybin and DMT bind at many different receptors at different strength. I've read of activity at D1, A2A, A2B, A2C, and tryptamines tend to also bind to many different serotonin receptors. For example psilocin and mescaline bind strongly to 5ht2b, but psilocin is only moderately active at 5ht2a and mescaline not at all. Or so my notes say, but I don't have a reliable source available. Just a heads up if anyone is paying attention. — Preceding unsigned comment added by 80.222.148.189 ( talk) 21:10, 9 April 2019 (UTC)
The following Wikimedia Commons file used on this page has been nominated for deletion:
Participate in the deletion discussion at the nomination page. — Community Tech bot ( talk) 22:22, 13 January 2020 (UTC)
There was a thread a few years ago on the proper scope of this page, which reached no definitive conclusion, but I think the matter needs to be settled. Basically the question comes down to this: should the page have a broad scope as it does now, covering (classic) psychedelics, empathogens, dissociatives, deliriants, and cannabinergics, or should it have a narrower scope, covering only classic psychedelics? Unfortunately, pages already exist corresponding to both those possible scopes: Hallucinogen and Serotonergic psychedelic respectively. Therefore, regardless of which names should be used for the pages for the two concepts, there is a problem because there are three pages.
This is what I think should be done. This page should then be reduced in scope to only cover classic psychedelics. This seems preferable to the topic being covered on the page "Serotonergic psychedelic," since that is a more technical term and in any case not the term used in most of the literature based on my sampling; that page's content can be merged into this one's, and it can become a redirect. Then, I think this page should have a longer section on nomenclature similar to the one on the "Hallucinogen" page to clear up confusion among readers. At the top of the article it could say "Psychedelics, serotonergic psychedelics, classic psychedelics, or classic hallucinogens are ...", to make immediately clear that several names are used for the same thing.
I wanted to check with other editors before making big changes, but if my plan sounds good, I will go ahead and start moving content on the other hallucinogens to the "Hallucinogen" page. Then I could propose a merger and the material from "Serotonergic psychedelic" could be moved here. Gazelle55 ( talk) 01:25, 27 May 2020 (UTC)
Based on my post just above, I'd like to formally propose merging Serotonergic psychedelic into this page. This page has only covered serotonergic/classic psychedelics for some time now and there is no reason to have two pages for the same concept (see above). There isn't much material on the other page anyway so it could easily be integrated here. Furthermore, the less common, broader definition of psychedelic drug is already covered at the article Hallucinogen. Following the merger, I would bring together some sources to clarify the confusing and sometimes overlapping uses of the terminology for readers. Gazelle55 ( talk) 16:28, 12 May 2022 (UTC)
A conversation about this article took place here. OP is concerned that the risks of psychedelics are under-emphasized in the article. Most of the responses are invocations of WP:FALSEBALANCE, WP:FRINGE, WP:OR, and so on. I think these all miss the point. You can see my comment there for more background. However, here is the final paragraph of my comment, which will hopefully start a collaborative discussion about how to improve the article pursuant to OP's concerns:
"I think a concrete improvement that can be made to the article to address OP's well-founded concerns is to include a mention of the "Potential adverse effects" section in the lede, rather than only presenting positive information in the lede. These adverse effects would ideally be mentioned directly after the passage that states "psychedelics are physiologically safe." Pecopteris ( talk) 19:39, 27 September 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 March 2024 and 4 May 2024. Further details are available
on the course page. Student editor(s):
Kph7917 (
article contribs).
— Assignment last updated by Kph7917 ( talk) 17:44, 1 April 2024 (UTC)